{"nct_id":"NCT05526755","title":"A Study of 5 Years of Adjuvant Osimertinib in Completely Resected Epidermal Growth Factor Receptor Mutation (EGFRm) Non-small Cell Lung Carcinoma (NSCLC)","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-08","start_date":"2023-03-06","start_date_type":"ACTUAL","primary_completion_date":"2029-11-22","primary_completion_date_type":"ESTIMATED","completion_date":"2029-11-22","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["AZN"]}